CLINICAL_TRIALS ClinicalTrials.gov record update

Romidepsin Therapy in Conditioning and Maintenance in Patients With T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02512497
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:17.418907+00:00
Published At: 2025-09-19T00:00:00+00:00
Record Updated At: 2025-09-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cutaneous T-cell Lymphoma", "T-Prolymphocytic Leukemia", "T-Large Granulocytic Leukemia", "T-Lymphoblastic Leukemia/Lymphoma", "Peripheral T-Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-19"
protocolSection.identificationModule.nctId: "NCT02512497"
protocolSection.identificationModule.officialTitle: "Romidepsin Therapy in Conditioning and Maintenance in Patients With T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.